Literature DB >> 9556152

Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients.

M Okada1, M Goto, Y Furuichi, M Sugimoto.   

Abstract

We studied the effects of nine cytotoxic drugs on three groups of B-lymphoblastoid cell lines transformed by Epstein-Barr virus (EBV): group 1, mortal cell lines from normal individuals; group 2, immortalized cell lines from normal individuals with strong telomerase activity; group 3, mortal cell lines from Werner's syndrome (WS) patients. Aminoglycoside antibiotics and alkylating drugs showed significantly stronger cytotoxic effects on immortalized cell lines than on mortal cell lines or the cell lines before immortalization. In contrast, topoisomerase II inhibitors showed no difference or they tended to be less cytotoxic to immortalized cell lines. Mortal cell lines from normal individuals and WS patients showed no difference in sensitivity against all the drugs examined except for the topoisomerase I inhibitor, camptothecin, which had a stronger cytotoxic effect on WS cell lines than other cell lines. We discuss the mechanisms underlying these cytotoxic effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9556152     DOI: 10.1248/bpb.21.235

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  11 in total

1.  Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.

Authors:  Ruben Agrelo; Wen-Hsing Cheng; Fernando Setien; Santiago Ropero; Jesus Espada; Mario F Fraga; Michel Herranz; Maria F Paz; Montserrat Sanchez-Cespedes; Maria Jesus Artiga; David Guerrero; Antoni Castells; Cayetano von Kobbe; Vilhelm A Bohr; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-24       Impact factor: 11.205

2.  Hyperinsulinemia and insulin resistance in Wrn null mice fed a diabetogenic diet.

Authors:  Gina Moore; Susan Knoblaugh; Kathryn Gollahon; Peter Rabinovitch; Warren Ladiges
Journal:  Mech Ageing Dev       Date:  2008-01-17       Impact factor: 5.432

3.  The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.

Authors:  Federico Innocenti; Snezana Mirkov; Ramamoorthy Nagasubramanian; Jacqueline Ramírez; Wanqing Liu; Wasim K Bleibel; Sunita J Shukla; Kathleen Hennessy; Gary L Rosner; Edwin Cook; M Eileen Dolan; Mark J Ratain
Journal:  Cancer Chemother Pharmacol       Date:  2008-08-02       Impact factor: 3.333

4.  The spectrum of WRN mutations in Werner syndrome patients.

Authors:  Shurong Huang; Lin Lee; Nancy B Hanson; Catherine Lenaerts; Holger Hoehn; Martin Poot; Craig D Rubin; Da-Fu Chen; Chih-Chao Yang; Heike Juch; Thomas Dorn; Roland Spiegel; Elif Arioglu Oral; Mohammed Abid; Carla Battisti; Emanuela Lucci-Cordisco; Giovanni Neri; Erin H Steed; Alexa Kidd; William Isley; David Showalter; Janet L Vittone; Alexander Konstantinow; Johannes Ring; Peter Meyer; Sharon L Wenger; Axel von Herbay; Uwe Wollina; Markus Schuelke; Carin R Huizenga; Dru F Leistritz; George M Martin; I Saira Mian; Junko Oshima
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

5.  WRN helicase expression in Werner syndrome cell lines.

Authors:  M J Moser; A S Kamath-Loeb; J E Jacob; S E Bennett; J Oshima; R J Monnat
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

6.  The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage.

Authors:  Frances J Mao; Julia M Sidorova; Julia M Lauper; Mary J Emond; Raymond J Monnat
Journal:  Cancer Res       Date:  2010-07-27       Impact factor: 12.701

7.  Homologous recombination resolution defect in werner syndrome.

Authors:  Yannick Saintigny; Kate Makienko; Cristina Swanson; Mary J Emond; Raymond J Monnat
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 8.  Roles of RECQ helicases in recombination based DNA repair, genomic stability and aging.

Authors:  Dharmendra Kumar Singh; Byungchan Ahn; Vilhelm A Bohr
Journal:  Biogerontology       Date:  2008-12-15       Impact factor: 4.277

9.  A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity.

Authors:  M Lebel; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

10.  Mouse WRN Helicase Domain Is Not Required for Spontaneous Homologous Recombination-Mediated DNA Deletion.

Authors:  Adam D Brown; Alison B Claybon; Alexander J R Bishop
Journal:  J Nucleic Acids       Date:  2010-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.